Replacement of rabbit pyrogen testing by an alternative test for plasma derived medicinal products - Scientific guideline
Table of contents
This document lays down the requirements to be addressed in any justification for use of a test for bacterial endotoxins as an alternative to a test for pyrogens for plasma derived medicinal products. It specifically, addresses the LAL-testing related issues, process related considerations, clinical considerations and regulatory aspects to be considered when replacing the test for pyrogens by an alternative test.
Keywords: Plasma derived medicinal products, rabbit pyrogen testing, bacterial endotoxin test, LAL test, monocyte activation test
-
List item
Overview of comments received on the guideline on the replacement of rabbit pyrogen testing by an alternative test for plasma derived medicinal products (EMEA/CHMP/BWP/452081/2007) (PDF/51.93 KB)
First published: 23/04/2009
Last updated: 23/04/2009
EMEA/CHMP/BWP/513210/2008 -
List item
Draft note for guidance on plasma derived medicinal products (CPMP/BWP/269/05 rev. 3) - Addendum on the replacement of rabbit pyrogen testing by an alternative test for plasma derived medicinal products (EMEA/CHMP/BWP/45... (PDF/99.4 KB)
Draft: consultation closed
First published: 05/12/2007
Last updated: 05/12/2007
EMEA/CHMP/BWP/452081/2007